What the studies show
Anxiolytic effects are reported in the Russian literature and in rodents; no controlled human trial.
Animal studies, cell studies, or anecdotes only. This is where almost every viral peptide sits. Promising and proven are different words for a reason.
In context
Noopept is a synthetic molecule built from the dipeptide proline-glycine, developed at the Zakusov Institute in Moscow and registered in Russia as a nootropic for mild cognitive impairment after brain injury or stroke. Outside Russia it is not approved anywhere. The human evidence is a single Russian comparison against piracetam in patients with vascular or traumatic cognitive impairment; its English translation carries no abstract in PubMed, and no independent group has replicated it. The claims made for it in healthy people — focus, memory, learning — have never been tested in a controlled trial.
Noopept (omberacetam) is not approved (outside russia). Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is Noopept (omberacetam) proven to help with anxiety?
What studies are behind the grade?
Is Noopept (omberacetam) approved for this?
Other outcomes for Noopept (omberacetam)
- DCognitive impairment after brain injury or stroke1 Russian comparative trial (vs piracetam)
- DCognition in healthy peopleNone
- DSafety in humansadverseNo systematic international data
Written and maintained by LYO Research — how pages are written and checked. Reviewed 10 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →